Pfizer Inc. Helps France Kick Butts
It's commonly believed that Europeans lead healthier lives than Americans. But anyone who's been to Europe knows that in one respect, that's not necessarily true: Smoking is far more common on the other side of the Atlantic, with 34% of E.U. citizens smoking, compared to 25% in the United States. To help alleviate this problem (and doubtlessly pursue a potential sales opportunity), pharmaceutical company Pfizer (NYSE: PFE) received approval from the EMEA today to market a pill named Champix that will help curb the urge to smoke.